Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice
Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice
复制标题
DOI:
10.1016/j.jphs.2018.09.006
复制
发表时间:
2018-09-01
影响因子:
3.5
通讯作者:
Minami, Masabumi
中科院分区:
文献类型:
--
作者:
Deyama, Satoshi;Shimoda, Kento;Minami, Masabumi
Eicosapentaenoic acid (EPA)-derived resolvin E1 (RvE1) and E2 (RvE2) have antidepressant effects. Here, we investigated the antidepressant effects of resolvin E3 (RvE3) in a mouse model of lipopolysaccharide (LPS)-induced depression. We observed that LPS (0.8 mg/kg, i.p.) significantly increased immobility time on the tail suspension test, and this depression-like behavior was dose-dependently attenuated by intracerebroventricular infusion of RvE3 (10 or 100 ng). No effects of LPS or intracerebroventricular infusion of RvE3 on locomotor activity were observed. These results indicate that RvE3, as well as RvE1 and RvE2, have antidepressant effects. (C) 2018 The Authors. Production and hosting by Elsevier B.V.